LexDanaLexDanabeta
Inventor

Gregg F. Keaney

Inventor
Lexington, MA, US

Overview

16→
Patents
2011–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 16 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes27%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
Y02ATechnologies for adaptation to climate change4%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
10,774,064Potassium channel modulators202010,752,633Heteroaromatic NMDA receptor modulators and uses thereof202010,745,387Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof202010,717,728Potassium channel modulators202010,584,131Heteroaromatic NMDA receptor modulators and uses thereof202010,351,553Potassium channel modulators20199,975,886Potassium channel modulators20189,879,293'Enzymatic transamination of cyclopamine analogs'20189,481,669'Pladienolide pyridine compounds and methods of use'20169,346,769'Tetrazolones as inhibitors of fatty acid synthase'20168,703,448'Enzymatic transamination of cyclopamine analogs'20148,609,706'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20138,546,432'Tetrazolones as inhibitors of fatty acid synthase'20138,450,350'Triazoles as inhibitors of fatty acid synthase'20138,178,690'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20127,928,244'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011–2018Based in Belmont, MA, US· patent location history
2012–2018Patents assigned to INFINITY PHARMACEUTICALS INC (6)· patent assignee history
2012–2014Patents assigned to KEANEY GREGG F (5)· patent assignee history
2012–2013Patents assigned to CASTRO ALFREDO C (4)· patent assignee history
2012–2013Patents assigned to NEVALAINEN MARTA (4)· patent assignee history
2013–2020Based in Lexington, MA, US· patent location history
2018–2020Patents assigned to CADENT THERAPEUTICS INC (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CADENT THERAPEUTICS INC62018–2020
INFINITY PHARMACEUTICALS INC62012–2018
KEANEY GREGG Fself52012–2014
CASTRO ALFREDO C42012–2013
NEVALAINEN MARTA42012–2013
Locations
LocationPatentsSpan
Lexington, Massachusetts, US122013–2020
Belmont, Massachusetts, US42011–2018